“ I believe that the future of obesity care will be multi-dimensional. In the next 5 to 10 years, we expect to stop talking about "obesity" and… ”
In Conversation
“ We are not moving boxes; we are safeguarding therapies destined for real people. ”
“ As healthcare stakeholders, we want industry to invest in R&D and develop new therapies, but we also need to make sure those therapies remain affordable and… ”
“ ...our priority is to actively contribute to the sustainability of innovation in Switzerland over time, ensuring that we not only lead the way but also work… ”
“ Alzheimer’s will not be solved by a single breakthrough, but by layered strategies that combine scientific precision with real-world applicability. ”
“ We stand at the threshold of a new era in neuroscience, and the 2020s and 2030s will be marked by profound therapeutic breakthroughs that were once… ”
Glorimar Torres – General Manager/Country Director, Executive Board Member of the PR Pharmaceutical Industry Association, Amgen
“ My legacy isn’t just about growing Amgen’s presence—it’s about reshaping Puerto Rico’s healthcare landscape, expanding access, and creating a future where every patient, regardless of their… ”
“ Our transition from public health to precision-targeted therapeutics reflects both the maturity of our platform and the ambition behind it. ”
“ Science is at the heart of everything we do in this region. It is the foundation of our reputation and the driving force behind the Medicon… ”
“ To establish Hong Kong as a serious global contender in biotechnology, it is not enough to allocate funding alone. What is required is the cultivation of… ”
“ "Our ambition is led by our ability to connect science, compliance, and commercial readiness across borders." ”
Guangjin Pan – Managing Director, Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Science
“ We aim to ensure that scientific discoveries translate into real-world innovations that benefit patients and society. ”